ClinicalTrials.gov
public full text
Public Domain
Total-Body FDG PET for Radiotherapy Response Assessment in Head and Neck Cancer
The overall goal of this research study is to understand how 18F-fluorodeoxyglucose (FDG), a radioactive sugar behaves in head and neck cancer (HNC) and inflammation immediately following injection and at many hours post-injection, with the world's first total-body positron emission tomography (PET)/computed tomography (CT) scanner (EXPLORER).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection#804697
- Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer#1103479
- Radiation Field, Dose and Fractionation Related to Mandibular Complications#1162596
- Clinical Study of 18F-LNC1007 Injection PET/CT#846517
- A Study Using Cone Beam CT for Head and Neck Cancer#848106
Record · ID 1060450
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive